Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

A Cancer Detection Test Fails in Major Study

The New York Times – Business:

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in later stages of the disease.

Rebecca Robbins
Author: Rebecca Robbins

This post first appeared in The New York Times – Business. Read the original article.

Written by

Rebecca Robbins

in

Cancer, Clinical Trials, DNA (Deoxyribonucleic Acid), Food and Drug Administration, Grail Inc, Health Insurance and Managed Care, Regulation and Deregulation of Industry, Research, Tests (Medical)
←Opendoor rises as JPMorgan boosts earnings estimates following Q4 results
Nvidia nears $30 billion investment in OpenAI’s funding round, the FT reports→

More posts

  • England won’t get carried away by All Blacks win

  • The Street Style Guide to Dressing for Thanksgiving

  • Adults are buying more toys than ever. You should too.

  • New Orleans Guide: Where to Stay, Eat, Drink, and Revel in the Big Easy

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube